PINNACLE ASSOCIATES LTD Ultragenyx Pharmaceutical Inc. Transaction History

PINNACLE ASSOCIATES LTD portfolio value:

$5.40M
portfolio value

PINNACLE ASSOCIATES LTD quarter portfolio value change:

-30.59%
quarter

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.72% -3.64K shares -2.59M $41.41 130.41K
Q2 2022 share Decrease -1.63% -2.22K shares -1.89M $59.66 134.05K
Q1 2022 share Decrease -3.74% -5.29K shares -2.00M $72.62 136.27K
Q4 2021 share Decrease -0.55% -782 shares -934K $84.25 141.57K
Q3 2021 share Decrease -2.84% -4.15K shares -1.13M $90.19 142.35K
Q2 2021 share Increase +0.84% 1.22K shares -2.57M $95.35 146.51K
Q1 2021 share Decrease -8.25% -13.06K shares -5.37M $113.86 145.29K
Q4 2020 share Decrease -5.56% -9.33K shares 8.13M $138.43 158.35K
Q3 2020 share Decrease -3.74% -6.51K shares 156K $82.19 167.68K
Q2 2020 share Increase 0.00% 174.19K shares 13.62M $78.22 174.19K